21Shares Amends Injective ETF Filing With Nasdaq Ticker TINJ
21Shares Amends Injective ETF Filing With Nasdaq Ticker TINJ
Prefer us on GoogleWEEX View
- The key next signal is whether the listing process advances beyond the amended registration statement. This filing updates the product structure, but it does not amount to launch approval.
- Markets should also watch how 21Shares handles two sensitive parts of the proposed structure: final custody arrangements and the possibility of staking a portion of the fund’s INJ holdings. Both could affect review timing and the final form of the product.
- For the broader altcoin ETF market, the filing adds another test of whether issuers can push beyond bitcoin and ether products into smaller single-asset funds with more specialized features.
21Shares has filed an amended S-1 registration statement for its proposed Injective ETF, seeking to list the product on Nasdaq under the ticker TINJ, according to the filing. The fund would track INJ through the FTSE Injective Index, while the product remains unapproved for listing and its custody arrangements are still being finalized.
The amended filing says the ETF would benchmark against the FTSE Injective Index and aims to give investors exposure to the INJ token through a traditional exchange-traded product. The filing also says the fund may use part of its INJ holdings for staking in order to earn staking rewards.
21Shares previously submitted the initial application for the product in October 2025. Deepened review of the filing history confirms that the original S-1 registration statement was filed on October 20, 2025, by 21Shares US LLC, placing the proposed fund into the SEC registration process.
The product is not yet cleared to list, and material details remain open. The current information indicates that custody arrangements have not been finalized, and no approval has been granted for trading on Nasdaq. The filing therefore marks a procedural step rather than a completed launch.
The amendment also fits into a wider expansion by 21Shares across single-asset crypto ETFs in the U.S. market. Other filings tied to digital assets such as Dogecoin and Hyperliquid suggest the issuer is continuing to test demand for crypto funds beyond the largest tokens, even as approval standards may vary from one asset and product design to another.
Why It Matters
The filing matters because it broadens the institutional ETF push into another non-BTC, non-ETH token and keeps the single-asset altcoin ETF theme active in the U.S. market. For Injective, a proposed Nasdaq-listed fund from a known issuer adds another channel through which traditional investors could eventually gain exposure without holding the token directly.
It also highlights an unresolved structural question in crypto ETFs: whether products that hold proof-of-stake assets can include staking features inside a regulated wrapper. That issue goes beyond INJ and could shape how future crypto commodity funds are designed, reviewed, and brought to market.
Milestones
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
About WEEX View
WEEX View is a crypto analysis and intelligence hub, covering the latest in Web3, AI, and global markets. Get independent research and in-depth insights to stay ahead of market trends and trading opportunities.
Latest articles
MoreCrypto Exchange Oversight Group Begins 18-Month Rulemaking Mandate
A temporary multi-agency working group has been launched to draft cryptocurrency exchange rules, issue licenses and supervise operations over 18 months, with a compliance timetable also due for existing platforms.
US Senate Cloture Vote Blocks CLARITY Act From Advancing
The US Senate failed to advance the CLARITY Act after a procedural cloture vote fell short of the 60-vote threshold, leaving crypto market-structure legislation stalled and SEC-CFTC jurisdiction questions unresolved.
GSR Report Flags Weak Post-Listing Performance Across Token Launches
GSR said its study of more than 2,300 token listings since 2013 found the median listing fell below its issue price within three days and was down nearly 50% by day 90, with high-FDV, low-float launches performing worst.
WaterPlum Used Fake Crypto Jobs to Breach 30,000 Devices
A joint law enforcement advisory said North Korean-linked group WaterPlum infected at least 30,000 devices in more than 100 countries and exfiltrated funds or credentials from over 7,000 crypto wallets, with at least $10.71 million traced to DPRK-linked control.
-- Price
Related assets
